Lifestyle modification approaches for the treatment of obesity in adults.
2020/02/01 by Thomas A. Wadden, Jena S. Tronieri, Jena Shaw Tronieri +1 · 33 citations
Medicine · Psychology · #Diet and metabolism studies #Eating Disorders and Behaviors #Obesity, Physical Activity, Diet
paper · doi:10.1037/amp0000517
Abstract
The U.S. Preventive Services Task Force has recommended that primary care clinicians screen all adults for obesity and provide those affected intensive multicomponent behavioral interventions. Approximately 95 million U.S. adults qualify for such care, also referred to as lifestyle modification. Using the Guidelines (2013) for Managing Overweight and Obesity in Adults (hereafter, Obesity Guidelines) as a framework, this article reviews the principal components of comprehensive lifestyle modification, which include diet, physical activity, and behavior therapy. To lose weight, the Obesity Guidelines recommend participation for 6 months in high-intensity programs that provide 14 or more counseling sessions with a trained interventionist. When provided face-to-face individual or group treatment, participants lose up to 8 kg (8% of weight) in 6 months and experience improvements in cardiovascular disease risk factors and quality of life. To prevent weight regain, the Obesity Guidelines recommend participation for 1 year in weight-loss-maintenance programs that provide at least monthly counseling. High levels of physical activity, frequent monitoring of body weight, and consumption of a reduced-calorie diet are associated with long-term weight loss. Investigators currently are seeking to increase the availability of lifestyle modification by delivering it in community-based programs, as well as on digital platforms (e.g., Internet and Smartphone). Digitally delivered programs lower costs and expand treatment reach; their efficacy is likely to improve further with the addition of new technologies for monitoring food intake, activity, and weight. Ultimately, to improve long-term weight management, individual lifestyle counseling must be joined with collective and institutional efforts to improve the nation's eating and activity environments. (PsycINFO Database Record (c) 2020 APA, all rights reserved).
Cited by
- Emerging pharmacotherapies for obesity: A systematic review
- The (dys)regulation of energy storage in obesity
- Benefits and Costs of Treating Obesity Among Adults in Commercial Insurance Plans
- The Cost of Inaction in Treating Obesity in the U.S.
- Hypothalamic regulation of obesity: Revealing the therapeutic potential of a novel anti-obesity peptide
- The Benefits and Costs of Treating Obesity Among Adults in the Medicaid Program
- The New Obesity Treatment Landscape: Challenges and Opportunities to Promote Shared Decision-Making in People With Obesity and Type 2 Diabetes
- What is the pipeline for future medications for obesity?
- A Bidirectional View of Migraine and Diet Relationship. [europepmc]
- Digital Therapeutics for Obesity and Eating-Related Problems. [europepmc]
- Role of weight bias and patient-physician communication in the underutilization of bariatric surgery. [europepmc]
- Improving lifestyle obesity treatment during the COVID-19 pandemic and beyond: New challenges for weight management. [europepmc]
- A Theory- and Evidence-Based Digital Intervention Tool for Weight Loss Maintenance (NoHoW Toolkit): Systematic Development and Refinement Study. [europepmc]
- The Complicated Relationship between Dieting, Dietary Restraint, Caloric Restriction, and Eating Disorders: Is a Shift in Public Health Messaging Warranted? [europepmc]
- Effects of Diet, Lifestyle, Chrononutrition and Alternative Dietary Interventions on Postprandial Glycemia and Insulin Resistance. [europepmc]
- Effects of Time-Restricted Feeding on Energy Balance: A Cross-Over Trial in Healthy Subjects. [europepmc]
- Electronic Health Record-Based Recruitment and Retention and Mobile Health App Usage: Multisite Cohort Study. [europepmc]
- Butyrate and obesity: Current research status and future prospect. [europepmc]
- Effect of High-Intensity Interval Training vs. Moderate-Intensity Continuous Training on Fat Loss and Cardiorespiratory Fitness in the Young and Middle-Aged a Systematic Review and Meta-Analysis. [europepmc]
- Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. [europepmc]
- The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities. [europepmc]
- 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2024. [europepmc]
- What is the pipeline for future medications for obesity? [europepmc]
- Overnutrition and Lipotoxicity: Impaired Efferocytosis and Chronic Inflammation as Precursors to Multifaceted Disease Pathogenesis. [europepmc]
- Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial. [europepmc]
- Efficacy and safety of once-weekly tirzepatide for weight management compared to placebo: An updated systematic review and meta-analysis including the latest SURMOUNT-2 trial. [europepmc]
- The interplay of factors in metabolic syndrome: understanding its roots and complexity. [europepmc]
- Role of Microbiota-Derived Hydrogen Sulfide (H 2 S) in Modulating the Gut-Brain Axis: Implications for Alzheimer's and Parkinson's Disease Pathogenesis. [europepmc]
- Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. [europepmc]
- Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. [europepmc]
- The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions. [europepmc]
- Obesity: Prevalence, causes, consequences, management, preventive strategies and future research directions. [europepmc]
- Weight regain after cessation of medication for weight management: systematic review and meta-analysis. [europepmc]
Related